ClinicalTrials.Veeva

Menu

Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status

Completed

Conditions

Parkinson Disease

Treatments

Drug: Glucose

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00004451
199/13548
K07MH001197 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study will determine whether glucose facilitates memory in healthy elderly people and those with Parkinson's disease.

Full description

Subjects fast for 8 hours before receiving a test to determine their blood glucose levels. Following this test, subjects are randomized to receive either a glucose or saccharin sweetened drink. A series of memory tests and an additional 3 blood glucose level tests are administered approximately 15 minutes later. A minimum of 1 week afterward, the subjects return and receive the alternate sweetener followed by additional memory tests.

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Three groups of subjects are eligible for this study: Healthy young adults between ages 18 and 30; Healthy elderly adults between ages 60 and 90; AND Anyone diagnosed with Parkinson's disease

Exclusion criteria

  • Prior surgery to remove part of the stomach
  • Diabetes, Addison's, or Cushing's diseases

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems